Screening for abnormal placentation and adverse pregnancy outcomes with maternal serum biomarkers in the second trimester

Angiogenic factors combined with clinical risk factors to predict preterm pre-eclampsia in nulliparous women: a predictive test accuracy study

(2013) JE Myers et al.   BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY

The value of early second trimester PAPP-A and ADAM12 in screening for pre-eclampsia

(2012) Jonathan P Bestwick et al.   JOURNAL OF MEDICAL SCREENING

ADAM 12 and PAPP-A at 14-17 weeks' gestation as biomarkers of pre-eclampsia

(2011) R. D'Anna et al.   PRENATAL DIAGNOSIS

Uterine artery Doppler and adverse pregnancy outcome in women with extreme levels of fetoplacental proteins used for Down syndrome screening

(2010) E. Filippi et al.   ULTRASOUND IN OBSTETRICS & GYNECOLOGY

Placental Growth Factor (PlGF) Is a Surrogate Marker in Preeclamptic Hypertension

(2008) Patrícia Gonçalves Teixeira et al.   HYPERTENSION IN PREGNANCY

First trimester maternal serum PAPP-A, β-hCG and ADAM12 in prediction of small-for-gestational-age fetuses

(2008) Kasper Pihl et al.   PRENATAL DIAGNOSIS

ADAM12s in maternal serum as a potential marker of pre-eclampsia

(2008) Kevin Spencer et al.   PRENATAL DIAGNOSIS

Maternal serum placental growth factor at 11 + 0 to 13 + 6 weeks of gestation in the prediction of pre-eclampsia

(2008) R. Akolekar et al.   ULTRASOUND IN OBSTETRICS & GYNECOLOGY

First-trimester maternal serum pregnancy-associated plasma protein-A and pre-eclampsia

(2008) L. C. Y. Poon et al.   ULTRASOUND IN OBSTETRICS & GYNECOLOGY

Predictive value of angiogenic factors and uterine artery Doppler for early- versus late-onset pre-eclampsia and intrauterine growth restriction

(2007) F. Crispi et al.   ULTRASOUND IN OBSTETRICS & GYNECOLOGY